| Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer (NCT04044430) | University of California, San Francisco | 2020-08-31 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer (NCT02728804) | SWOG Cancer Research Network | 2016-06-22 |
| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver (NCT02110953) | Fox Chase Cancer Center | 2016-01-29 |
| Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer (NCT02393755) | Roswell Park Cancer Institute | 2015-05-08 |
| Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer (NCT02235324) | University of Southern California | 2015-03-01 |
| CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02232152) | Wake Forest University Health Sciences | 2015-01-06 |
| Programs to Support You During Chemotherapy (Pro-You) (NCT02148406) | Vanderbilt-Ingram Cancer Center | 2014-08-01 |
| MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer (NCT02041481) | City of Hope Medical Center | 2014-06-01 |
| Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy (NCT01941173) | City of Hope Medical Center | 2014-01-01 |
| Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520) | City of Hope Medical Center | 2013-10-01 |
| PET-MRI in Diagnosing Patients With Colon or Rectal Cancer (NCT01807117) | Case Comprehensive Cancer Center | 2013-04-01 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy (NCT01806675) | Sanjiv Sam Gambhir | 2013-03-04 |
| A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer (NCT01729923) | University of Washington | 2013-03-01 |
| Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery (NCT01802320) | National Cancer Institute (NCI) | 2013-03-01 |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors (NCT01217450) | National Cancer Institute (NCI) | 2012-10-01 |
| Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer (NCT01383343) | National Cancer Institute (NCI) | 2011-08-01 |
| Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer (NCT01365910) | Vanderbilt-Ingram Cancer Center | 2011-06-01 |
| Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer (NCT01320683) | City of Hope Medical Center | 2011-03-01 |
| Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer (NCT01270438) | National Cancer Institute (NCI) | 2010-12-01 |
| Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer (NCT01198535) | National Cancer Institute (NCI) | 2010-09-01 |
| Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors (NCT01131234) | National Cancer Institute (NCI) | 2010-05-01 |
| Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer (NCT01637194) | Fox Chase Cancer Center | 2008-11-01 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy (NCT00499369) | National Cancer Institute (NCI) | 2007-06-01 |
| SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT00103311) | National Cancer Institute (NCI) | 2005-01-01 |
| GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors (NCT00084643) | National Cancer Institute (NCI) | 2004-05-01 |
| Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer (NCT00077298) | National Cancer Institute (NCI) | 2003-12-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00005036) | National Cancer Institute (NCI) | 1999-11-01 |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer (NCT00002796) | National Cancer Institute (NCI) | 1997-05-01 |
| Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508) | Roswell Park Cancer Institute | |